Nexgard Spectra


afoxolaner / milbemycin oxime

This medicine is authorised for use in the European Union.


Nexgard Spectra is a veterinary medicine used to treat infestations with fleas, ticks, as well as demodectic and sarcoptic mange (skin infestations caused by two different types of mites) in dogs when prevention of heartworm disease (caused by a roundworm that infects the heart and blood vessels and is transmitted by mosquitoes), angiostrongylosis (caused by lungworms) and/or treatment of gut worms (hookworms, roundworms and whipworm) is also required.

Nexgard Spectra contains the active substances afoxolaner and milbemycin oxime.

This EPAR was last updated on 16/07/2019

Authorisation details

Product details
Nexgard Spectra
Agency product number
Active substance
  • afoxolaner
  • milbemycin oxime
International non-proprietary name (INN) or common name
afoxolaner / milbemycin oxime
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Date of issue of marketing authorisation valid throughout the European Union
Contact address

29 avenue Tony Garnier
69007 Lyon

Product information

16/05/2019 Nexgard Spectra - EMEA/V/C/003842 - IB/0020


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiparasitic products
  • milbemycin oxime combinations

Therapeutic indication

For the treatment of flea and tick infestations when the concurrent prevention of heartworm disease, angiostrongylosis  and/or treatment of gastrointestinal nematode infestations is indicated.

Treatment of flea infestations (Ctenocephalides felis and C. canis).

Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Rhipicephalus sanguineus).

Treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum, Ancylostoma braziliense and Ancylostoma ceylanicum) and whipworm (Trichuris vulpis).

Treatment of demodicosis (caused by Demodex canis).

Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis).

Prevention of heartworm disease (Dirofilaria immitis larvae).

Prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).

Assessment history

How useful was this page?

Add your rating